Interceptor Flavor 2,3 mg tablets for dogs
Interceptor Flavor 2,3 mg tablets for dogs
Authorised
- Milbemycin oxime
Product identification
Medicine name:
Interceptor Flavor 2,3 mg tablets for dogs
Interceptor Flavor 2,3 mg compresse per cani
Active substance:
- Milbemycin oxime
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Milbemycin oxime2.30/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP54AB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Available in:
-
Italy
Package description:
- Cardboard box with 5 double sided aluminium blisters consisting of aluminium forming and lidding foils, each blister contains 6 tablets
- Cardboard box with two double sided aluminium blisters consisting of aluminium forming and lidding foils, each blister contains 4 tablets
- Cardboard box with double sided aluminium blister consisting of aluminium forming and lidding foils containing 6 tablets
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Novartis Sante Animale
Responsible authority:
- Ministry Of Health
Authorisation number:
- 104293
Date of authorisation status change:
Reference member state:
-
Italy
Procedure number:
- IT/V/0124/001
Concerned member states:
-
Denmark
-
Finland
-
Greece
-
Norway
-
Portugal
-
Spain
-
Sweden
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 12/05/2023
Italian (PDF)
Published on: 19/05/2023
How useful was this page?:
